Ticker > Company >

Max Healthcare Inst share price

Max Healthcare Institute Ltd.

NSE: MAXHEALTH BSE: 543220 SECTOR: Hospital & Healthcare Services  2.14 L   686   169

1013.70
+6.80 (0.68%)
BSE: Today, 02:55 PM

Price Summary

Today's High

₹ 1021.5

Today's Low

₹ 1002.7

52 Week High

₹ 1314.3

52 Week Low

₹ 903.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

98652.52 Cr.

Enterprise Value

98737.85 Cr.

No. of Shares

97.32 Cr.

P/E

142.81

P/B

11.36

Face Value

₹ 10

Div. Yield

0.15 %

Book Value (TTM)

₹  89.26

CASH

416.5 Cr.

DEBT

501.83 Cr.

Promoter Holding

23.72 %

EPS (TTM)

₹  7.1

Sales Growth

13.76%

ROE

8.88 %

ROCE

11.84%

Profit Growth

2.01 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 43Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.76%
3 Year14.48%
5 Year114.06%

Profit Growth

1 Year2.01%
3 Year28.36%
5 Year198.97%

ROE%

1 Year8.88%
3 Year9.58%
5 Year6.09%

ROCE %

1 Year11.84%
3 Year10.77%
5 Year7.74%

Debt/Equity

0.0614

Price to Cash Flow

164.97

Interest Cover Ratio

20.5644

CFO/PAT (5 Yr. Avg.)

1.14648999204342

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 23.72 0.00
Sep 2025 23.74 0.00
Jun 2025 23.74 0.00
Mar 2025 23.74 0.00
Dec 2024 23.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 28.3563079490194% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 20.5644.
  • The Company has been maintaining an effective average operating margins of 26.8825276815615% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -140.6137 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.14648999204342.

 Limitations

  • The company has shown a poor revenue growth of 14.4792928003083% for the Past 3 years.
  • Company has contingent liabilities of 2012.53 Cr.
  • The company is trading at a high PE of 142.81.
  • The company is trading at a high EV/EBITDA of 90.8468.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 697.4 658.7 694.02 736.62 710.91
Total Expenditure 461.36 484.09 506.31 522.95 506.58
Operating Profit 236.04 174.61 187.71 213.67 204.33
Other Income 92.01 98.15 79.85 47.43 83.33
Interest 23.47 9.43 9.25 8.67 10.75
Depreciation 32.77 36.1 35.43 36.77 36.07
Exceptional Items -73.63 0 0 0 -15.64
Profit Before Tax 198.18 227.23 222.88 215.66 225.2
Tax 59.94 49.84 56.85 55.24 38.25
Profit After Tax 138.24 177.39 166.03 160.42 186.95
Adjusted EPS (Rs) 1.42 1.82 1.71 1.65 1.92

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1030.78 1775.36 1904.66 2341.36 2663.6
Total Expenditure 869.88 1340.3 1321.5 1581.99 1831.3
Operating Profit 160.9 435.06 583.16 759.37 832.3
Other Income 106.51 136.32 145.1 273.89 367.63
Interest 112.45 58.93 51.91 51.66 48.39
Depreciation 90.75 111.96 113.21 116.64 131.19
Exceptional Items -210.67 0 0 0 -73.63
Profit Before Tax -146.46 400.49 563.14 864.96 946.72
Tax 17.99 68.97 -131.17 177.7 245.65
Net Profit -164.45 331.52 694.31 687.26 701.07
Adjusted EPS (Rs.) -1.7 3.42 7.15 7.07 7.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 965.95 969.61 970.92 971.91 972.14
Total Reserves 4973.48 5341.77 6071.19 6708.85 7317.21
Borrowings 316.92 382.4 428.85 313.44 469.87
Other N/C liabilities 611.45 818.75 508.19 562.63 624.6
Current liabilities 275.15 299.23 441.18 512.04 583.4
Total Liabilities 7142.95 7811.76 8420.33 9068.87 9967.22
Assets
Net Block 2988.96 4493.02 4484.64 4716.87 4866.16
Capital WIP 8.15 14.06 57.03 128.51 240.32
Intangible WIP 0.19 46.19 45.82 106.53 36.63
Investments 2379.3 1447.01 1474.74 1915.36 2613.71
Loans & Advances 802.31 963.03 852.84 1106.93 1288.98
Other N/C Assets 2.19 136.01 69.21 67.91 93.33
Current Assets 961.85 712.44 1436.05 1026.76 828.09
Total Assets 7142.95 7811.76 8420.33 9068.87 9967.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -146.46 400.49 563.14 864.96 946.72
Adjustment 309.87 77.13 61.49 -62.81 -113.79
Changes in Assets & Liabilities 37.92 12.57 160.09 -40.5 -53.6
Tax Paid 23.14 -42.83 -88.25 -148.69 -181.32
Operating Cash Flow 224.47 447.36 696.47 612.96 598.01
Investing Cash Flow -104.87 -669.65 301.69 -805.64 -873.26
Financing Cash Flow 412.41 -161.48 -54.47 -245.91 -28.81
Net Cash Flow 532.01 -383.77 943.69 -438.59 -304.06

Corporate Actions

Investors Details

PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
promoters 23.74 23.74 23.74 23.74 23.72
abhay soi 23.73 23.73 23.73 23.73 23.72
aditya soi 0.01 0.01 0.01 0.01 0.01
PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
investors 76.26 76.26 76.26 76.26 76.28
axis max life insurance l... - - - 1.05 1.49
canara robeco mutual fund... - - - - 1.32
government of singapore 5.92 5.69 5.07 4.28 3.40
government pension fund g... 1.12 1.09 1.14 1.17 1.21
hdfc mutual fund through ... - - - - 1.12
invesco mutual fund throu... - - - - 1.34
kotak funds - india midca... 1.06 1.06 1.06 - 1.03
kotak mahindra mutual fun... - - - - 1.33
llp 0.09 0.08 0.08 0.08 0.08
monetary authority of sin... 1.38 1.49 1.43 1.25 1.04
new world fund inc 6.11 5.33 5.33 4.72 4.72
nippon india mutual fund ... - - - - 1.24
sbi mutual fund through v... - - - - 2.59
smallcap world fund, inc 4.22 3.55 3.31 3.17 2.90
vanguard emerging markets... - - - 1.01 1.03
vanguard total internatio... 1.07 1.08 1.10 1.11 1.12
wf asian smaller companie... - - - - 1.01
canara robeco mutual fund... 1.29 1.28 1.28 1.27 -
kotak mutual fund - 1.08 - 1.27 -
nippon india mutual fund - - - 1.11 -
sbi mutual fund 2.37 1.74 1.54 2.57 -
axis mutual fund - 1.02 1.01 - -
hdfc life insurance compa... - 1.01 1.06 - -
motilal oswal mutual fund... 1.05 1.36 1.39 - -
nps trust- a/c icici prud... - - 1.04 - -
hdfc mutual fund 1.84 1.76 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
Credit CARE
Credit CARE
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research Geojit
Research Way 2 Wealth
Research Geojit
Research IDBI Capital
Research NuvamaWealth
Research Nuvama Wealth
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY25
Concall Q3FY25
Concall Q3FY24
Concall Q3FY24
Concall Q3FY21
Concall Q2FY26
Concall Q2FY21
Concall Q1FY26
Concall Q1FY25
Concall Q1FY23
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY21
Presentation Q3FY26
Presentation Q3FY26
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY23
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY21

Company News

Max Healthcare Institute soars on inking pact to acquire controlling stake in Kalinga Hospital 8 Apr, 2:51 PM Max Healthcare Institute inks pact to acquire controlling stake in Kalinga Hospital 8 Apr, 2:42 PM Max Healthcare Institute informs about grant of options 17 Mar, 10:16 AM Max Healthcare Institute informs about allotment of equity shares 17 Mar, 10:15 AM Max Healthcare Institute informs about audio recording of earnings call 7 Feb, 3:23 PM Max Healthcare Institute informs about newspaper clippings 7 Feb, 12:47 PM Max Healthcare Inst - Quaterly Results 6 Feb, 12:00 AM Max Healthcare Institute gains on reporting 26% rise in Q3 consolidated net profit 5 Feb, 3:21 PM Max Healthcare Institute reports 26% rise in Q3 consolidated net profit 5 Feb, 3:10 PM Max Healthcare Institute signs MoU with The Learning Lab 6 Jan, 3:29 PM Max Healthcare Institute informs about allotment under ESOS 2 Jan, 12:13 PM Max Healthcare Institute informs about outcome of board meeting 18 Dec, 3:57 PM Max Healthcare Institute informs about acquisition 18 Dec, 2:57 PM Max Healthcare to acquire 100% stake in Yerawada Properties 18 Dec, 2:21 PM Max Healthcare Institute joins hands with Australia-based Monash University 2 Dec, 3:58 PM Max Healthcare Institute reports 74% jump in Q2 consolidated net profit 15 Nov, 1:02 PM Max Healthcare Institute informs about disclosure 22 Sep, 2:53 PM Max Healthcare Institute informs about outcome of board meeting 13 Aug, 2:37 PM Max Healthcare Institute informs about press release 13 Aug, 1:22 PM Max Healthcare Inst - Quaterly Results 13 Aug, 12:19 PM Max Healthcare Inst - Quaterly Results 13 Aug, 12:19 PM Max Healthcare Inst - Quaterly Results 13 Aug, 12:19 PM Max Healthcare Institute informs about outcome of committee meet 12 Aug, 12:14 PM Max Healthcare Institute transfers equity shares of Sandhya Hydro Power Projects Balargha 14 Jul, 11:53 AM Max Healthcare Institute reports 27% jump in Q4 consolidated net profit 21 May, 3:12 PM Max Healthcare Inst - Quaterly Results 20 May, 2:42 PM Max Healthcare Inst - Quaterly Results 20 May, 2:42 PM Max Healthcare Inst - Quaterly Results 20 May, 2:42 PM Max Healthcare Institute’s arm executes sale deed for acquisition of land and building in UP 17 May, 11:12 AM Max Healthcare Institute planning to invest Rs 6,000 crore by 2028 29 Apr, 4:44 PM Max Healthcare Institute informs about disclosure 22 Mar, 11:57 AM Max Healthcare Institute gets nod to enter into agreement with BPCM 13 Mar, 2:42 PM Max Healthcare Institute gets nod for agreement to lease for setting up hospital at Thane 30 Jan, 3:52 PM Max Healthcare Inst - Quaterly Results 30 Jan, 2:14 PM Max Healthcare Inst - Quaterly Results 30 Jan, 2:14 PM Max Healthcare Inst - Quaterly Results 30 Jan, 2:14 PM Max Healthcare Institute informs about allotment of equity shares under ESOS 29 Jan, 11:33 AM Max Healthcare’s arm acquires additional equity stake in Starlit Medical Centre 28 Jan, 11:43 AM Max Healthcare Institute informs about disclosure 23 Jan, 5:16 PM Max Healthcare Institute informs about change of name of RTA 1 Jan, 5:00 PM Max Healthcare Institute completes acquisition of 100% equity stake of Jaypee Healthcare 12 Nov, 10:13 AM Max Healthcare Institute informs about update on acquisition 12 Nov, 9:57 AM Max Healthcare Inst - Quaterly Results 5 Nov, 9:14 PM Max Healthcare Inst - Quaterly Results 5 Nov, 9:14 PM Max Healthcare Institute to acquire 63.65% stake in Jaypee Healthcare 27 Sep, 10:12 AM Max Healthcare Institute informs about completion of tenure of independent director 26 Sep, 9:54 AM Max Healthcare Institute enters into strategic collaboration with Lakshdeep Group 13 Sep, 3:44 PM Max Healthcare Institute informs about allotment under ESOP 13 Sep, 3:03 PM Max Healthcare Institute informs about disclosure 13 Sep, 2:41 PM Max Healthcare to ink lease arrangement with Silicon Constructions for hospital in Punjab 1 Aug, 3:57 PM

Max Healthcare Inst Stock Price Analysis and Quick Research Report. Is Max Healthcare Inst an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Max Healthcare Inst. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Max Healthcare Inst has a PE ratio of 142.402299174439 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Max Healthcare Inst has ROA of 7.3657% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Max Healthcare Inst has a Current ratio of 1.4194.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Max Healthcare Inst has a ROE of 8.8839%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Max Healthcare Inst has a Debt to Equity ratio of 0.0614 which means that the company has low proportion of debt in its capital.

  • Sales growth: Max Healthcare Inst has reported revenue growth of 13.7629% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Max Healthcare Inst for the current financial year is 31.2471842619012%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Max Healthcare Inst is Rs 1.5 and the yield is 0.1486%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Max Healthcare Inst is Rs 7.0982. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Max Healthcare Inst in Ticker for free. Also, one can get the intrinsic value of Max Healthcare Inst by using Valuation Calculators, which are available with a Finology ONE subscription. 

Max Healthcare Inst FAQs

Q1. What is Max Healthcare Inst share price today?
Ans: The current share price of Max Healthcare Inst is Rs 1010.8.

Q2. What is the market capitalisation of Max Healthcare Inst?
Ans: Max Healthcare Inst has a market capitalisation of Rs 98370.29810216 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Max Healthcare Inst?
Ans: The PE ratio of Max Healthcare Inst is 142.402299174439 and the P/B ratio of Max Healthcare Inst is 11.3242848100202, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Max Healthcare Inst share?
Ans: The 52-week high share price of Max Healthcare Inst is Rs 1314.3, and the 52-week low share price of Max Healthcare Inst is Rs 903.

Q5. Does Max Healthcare Inst pay dividends?
Ans: Currently, Max Healthcare Inst pays dividends. Dividend yield of Max Healthcare Inst is around 0.1486%.

Q6. What are the face value and book value of Max Healthcare Inst shares?
Ans: The face value of Max Healthcare Inst shares is Rs 10, while the book value per share of Max Healthcare Inst is around Rs 89.2595. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Max Healthcare Inst?
Ans: Max Healthcare Inst has a total debt of Rs 501.83 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Max Healthcare Inst?
Ans: The ROE of Max Healthcare Inst is 8.8839% and ROCE of Max Healthcare Inst is 11.8376%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Max Healthcare Inst a good buy for the long term?
Ans: The Max Healthcare Inst long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Max Healthcare Inst undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Max Healthcare Inst appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Max Healthcare Inst’s financials?
Ans: You can review Max Healthcare Inst’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Max Healthcare Inst

Max Healthcare Institute Share Price, Stock Analysis & Company Profile

Max Healthcare Institute Limited is one of India’s leading private healthcare providers, operating a network of multi-speciality hospitals across major cities. Known for its advanced clinical infrastructure, strong doctor network, and focus on tertiary and quaternary care, the company plays a significant role in India’s organised healthcare sector.

This page serves as a comprehensive resource for investors to track the Max Healthcare Institute share price on NSE and BSE, along with key financial and operational insights required for detailed stock analysis.

Stay updated with broader healthcare sector trends and benchmark Max Healthcare Institute's movement against the overall market - Check market data and sector performance now.

About Max Healthcare Institute

Max Healthcare Institute Limited is headquartered in New Delhi and is part of the Max Group. The company operates a chain of hospitals primarily in North India, with a growing presence in other regions.

The hospital network focuses on high-end medical services, including oncology, cardiology, neurosciences, orthopaedics, and organ transplants. Over the years, Max Healthcare has built a strong reputation for clinical excellence, patient care, and operational efficiency.

The company has consistently expanded its capacity through brownfield and greenfield projects, along with strategic acquisitions, strengthening its position in the private healthcare ecosystem.

Max Healthcare Institute Business Model

Max Healthcare operates a hospital-led, asset-heavy business model focused on high-margin specialised care.

  • Hospital Services: Provides inpatient and outpatient services across multiple specialities, generating revenue through surgeries, diagnostics, and treatment procedures.
     
  • Specialised Care Segments: Strong focus on high-value treatments such as oncology, cardiac care, neurology, and organ transplants, which drive higher average revenue per occupied bed (ARPOB).
     
  • Diagnostics & Allied Services: Includes pathology, radiology, and pharmacy services, enhancing overall revenue per patient and improving operational integration.
     
  • Capacity Expansion: Growth strategy includes adding beds in existing hospitals and developing new facilities in high-demand urban markets.
     
  • Operational Efficiency: Focuses on improving occupancy rates, cost control, and optimising doctor utilisation to enhance profitability.

Diversify beyond a single PSU bank stock like IOB with curated portfolios - Discover ready-made stock bundles tailored to your goals.

Max Healthcare Institute Listing and IPO Details

Max Healthcare Institute is listed on major Indian stock exchanges and is widely tracked in the healthcare and hospital sector.

  • NSE Symbol: MAXHEALTH
  • BSE Scrip Code: 543220
  • Face Value: Rs 10 per share
  • ISIN: INE027H01010

Sector Classification

The company is categorised under the healthcare services sector, specifically hospital chains, and is often analysed for growth in healthcare demand, occupancy trends, and pricing power.
Track upcoming IPO opportunities similar to PSU banking investments - Browse the latest IPO listings and details today.

Max Healthcare Institute Corporate Action History

Max Healthcare’s corporate actions reflect its growth-oriented strategy and improving financial performance.

Stock Split History

The company has maintained a stable capital structure and has not frequently undertaken stock splits.

Dividend History

Max Healthcare has adopted a balanced dividend policy, considering expansion needs and profitability.

  • FY 2023-24: Declared dividend reflecting strong earnings and cash flow generation
     
  • FY 2022-23: Continued dividend payouts supported by improved operational performance

Healthcare companies typically balance dividends with reinvestment into infrastructure and expansion.

Investor Resources Available on This Page

Investors can access the following data points for a comprehensive Max Healthcare stock analysis:

  • Price Chart: Track real-time and historical share price trends (data may be delayed by 15 minutes)
     
  • Key Ratios: Metrics such as EBITDA margin, ROCE, ARPOB, and occupancy rate
    Identify stocks with similar financial metrics as IOB using advanced filters - Start screening stocks via using the Finology Screener based on your criteria now.
     
  • Quarterly Results: Revenue growth, profit trends, operating margins, and cost structure
     
  • Balance Sheet & Cash Flow: Capital expenditure, debt levels, and cash generation
     
  • Shareholding Pattern: Promoter holding, institutional investors, and public shareholding
     
  • Pros & Cons: Snapshot of strengths like premium positioning vs risks like high capital intensity
     
  • Annual Reports: Access official filings and investor presentations

Strengthen your investment decisions with structured learning and tools - Access the top investors resources and insights now.

Frequently Asked Questions

Q1. What is the latest Max Healthcare Institute share price?
The current share price is displayed at the top of this page. Data from NSE and BSE may be delayed by up to 15 minutes.

Q2. What does Max Healthcare Institute do?
Max Healthcare operates a network of multi-speciality hospitals offering advanced medical treatments, diagnostics, and healthcare services across India.

Q3. Does Max Healthcare Institute pay dividends?
Yes, the company pays dividends based on profitability, cash flows, and expansion requirements.

Q4. What is the face value of Max Healthcare shares?
The face value of each equity share is Rs 10.

Q5. Is Max Healthcare a good long-term investment?
Max Healthcare is considered a strong player in India’s growing healthcare sector, driven by rising demand and premium healthcare services. However, investors should evaluate valuations and risks.

Q6. Where can I find the latest Max Healthcare Annual Report?
You can access the latest annual reports and financial disclosures from the Reports or Documents section available on this page.

Q7. What factors impact Max Healthcare’s profitability?
Key factors include occupancy rates, ARPOB (Average Revenue Per Occupied Bed), cost management, expansion strategy, and demand for specialised healthcare services.

Read More
X